In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Adult patients with locally advanced or metastatic ROS1 positive non-small cell ···【more】
Release date:2026-01-05Recommended:281
Non small cell lung cancer with MET gene exon 14 mutation positive and unresecta···【more】
Release date:2026-01-05Recommended:244
iIndicated for the treatment of adult and pediatric patients 12 years and older ···【more】
Release date:2026-01-05Recommended:209
Deucravacitinib is suitable for treating plaque psoriasis.【more】
Release date:2026-01-05Recommended:261
Momelotinib is indicated for the treatment of intermediate or high-risk myelofib···【more】
Release date:2026-01-05Recommended:310
Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Release date:2026-01-05Recommended:276
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insuff···【more】
Release date:2026-01-05Recommended:295
Daprodustat is indicated for the treatment of anemia due to chronic kidney disea···【more】
Release date:2026-01-05Recommended:246
The first-line treatment for metastatic non-small cell lung cancer with epiderma···【more】
Release date:2026-01-05Recommended:343
Used for the treatment of relapsed or refractory FLT3-ITD mutation positive acut···【more】
Release date:2026-01-05Recommended:230
Valcyte treatment for cytomegalovirus infection.【more】
Release date:2026-01-05Recommended:319
Vemurafenib can treat melanoma and Erdheim Chester Disease.【more】
Release date:2026-01-05Recommended:251